Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Condylomata Acuminata 2Keratosis, Actinic 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 11Vaccines, Synthetic 10Papillomavirus Vaccines 5Vaccines 3Imiquimod 3Gels 3green tea extract polyphenone E 2Duration of Therapy 2ranpirnase 1polyphenon E 1berdazimer sodium 1Viusid 1VP-102 1Therapies, Investigational 1Tea 1Omiganan 1Ointments 1GS-9191 1Cidofovir 1Cantharidin 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Condylomata Acuminata × green tea extract polyphenone E × Clear all
NCT01490008 2012-04-19

Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers

MediGene

Phase 1 Completed
30 enrolled

Condylomata Acuminata

NCT01082302 2010-09-08

Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage

MediGene

Phase 4 Completed
43 enrolled

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡